Eledon Pharmaceuticals, Inc. Proceeds from Issuance of Redeemable Convertible Preferred Stock
Eledon Pharmaceuticals, Inc. (ELDN) reported Proceeds from Issuance of Redeemable Convertible Preferred Stock of $35.41 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock · last filed 2016-03-10
- Eledon Pharmaceuticals, Inc. proceeds from issuance of redeemable convertible preferred stock for the quarter ending 2013-12-31 was $15.48M.
- Eledon Pharmaceuticals, Inc. proceeds from issuance of redeemable convertible preferred stock for fiscal 2013 was $35.41M, a 88.58% increase from fiscal 2012.
- Eledon Pharmaceuticals, Inc. proceeds from issuance of redeemable convertible preferred stock for fiscal 2012 was $18.77M.
| Period end | Proceeds from Issuance of Redeemable Convertible Preferred Stock 3 month | Proceeds from Issuance of Redeemable Convertible Preferred Stock 9 month | Proceeds from Issuance of Redeemable Convertible Preferred Stock 12 month |
|---|---|---|---|
| 2013-12-31 | $15.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $35.41M 10-K · filed 2016-03-10 | |
| 2013-09-30 | $19.92M 10-Q · filed 2014-11-13 | ||
| 2012-12-31 | $18.77M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |